Related Experiment Video
Updated: Mar 29, 2026

10:28
Biological Compatibility Profile on Biomaterials for Bone Regeneration
Published on: November 16, 2018
13.5K
Therapeutic Biomaterials for Chronic Osteomyelitis: Time-Space-Control Strategies for Infection Control and Bone
Jinqiu Tian1,2,3,4,5, Qi Meng1,2,3,4, Peixun Zhang1,2,3,4,6
1Department of Trauma and Orthopaedics, Peking University People's Hospital, Beijing 100044, China.
Journal of Functional Biomaterials
|March 27, 2026
Summary
New biomaterials for chronic osteomyelitis (infected bone defects) manage infection and promote bone regeneration. These materials use programmed timing, targeted delivery, and controlled release for better outcomes.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Infectious Diseases
Background:
- Chronic osteomyelitis and infected bone defects involve persistent biofilms, immune dysfunction, and impaired bone healing.
- Conventional treatments often fail due to inability to address the complex interplay of infection and regeneration.
Purpose of the Study:
- To review how biofilm-associated immune dysfunction affects angiogenesis and osteogenesis.
- To summarize biomaterials designed to simultaneously control infection and promote tissue regeneration.
- To propose a framework for developing advanced therapeutic biomaterials for bone repair.
Main Methods:
- Literature review focusing on biofilm-associated immune dysfunction and regenerative biomaterials.
- Integration of representative biomaterial platforms into a "Time-Space-Control" framework.
- Development of a 4P principle for guiding programmable therapeutic biomaterials.
Main Results:
- Biomaterials can be designed with time-programmed release of antimicrobial and regenerative cues.
- Space-focused designs enhance localization and penetration into infected bone defects.
- Controllable strategies allow for pathology-responsive or externally triggered modulation of therapeutic effects.
Conclusions:
- A "Time-Space-Control" framework and 4P principle can guide the development of biomaterials for chronic infected bone repair.
- Explicitly managing timing, localization, and controllability is crucial for aligning antimicrobial therapy, immune reprogramming, and regenerative support.
- This approach holds promise for improving treatment strategies for challenging bone infections and defects.

